数百万人有资格接种拯救生命的带状疱疹疫苗，敦促立即采取行动

An in-depth investigation reveals how Merck's pricing and patents on the lifesaving cancer drug Keytruda have made it one of the world's top-selling medicines, while leaving many patients unable to afford it.

New research reveals private companies made £1.6 billion in profits from NHS contracts over 2 years, with millions going to firms in tax havens. Critics demand a cap on profits.